Medindia
Advertisement

Researchers Tame the Inflammatory Response in Kidney Dialysis

by Vishnuprasad on December 13, 2014 at 7:32 PM
Font : A-A+

Researchers Tame the Inflammatory Response in Kidney Dialysis

Frequent kidney dialysis is essential for the approximately 350,000 end-stage renal disease (ESRD) patients in the United States. But it can also cause systemic inflammation, leading to complications such as cardiovascular disease and anemia, and patients who rely on the therapy have a five-year survival rate of only 35 percent. Such inflammation can be triggered when the complement cascade, part of the body's innate immune system, is inadvertently activated by modern polymer-based dialysis blood filters.

New work by Penn researchers has found an effective way to avoid these problems by temporarily suppressing complement during dialysis. Their work appears online in Immunobiology ahead of print.

Advertisement

Over the past several years, lead author John Lambris, PhD, the Dr. Ralph and Sallie Weaver Professor of Research Medicine, Perelman School of Medicine at the University of Pennsylvania, and his colleagues have developed small molecule versions of the drug compstatin, which inhibits a component of the complement immune response called C3. Lambris explains that this next-generation compound, called Cp40, "is a small peptide similar to cyclosporine in many aspects, however it uses a different mechanism of action."

Previous studies by Lambris and his team, in which modern polymer-based hemodialysis filters were perfused with human blood, showed significant complement activation and an increase in inflammatory biomarkers. This response could be suppressed using compstatin, suggesting that it might be used in dialysis to decrease the inflammatory response side effect.
Advertisement

The new study took place in non-human primates to validate Cp40's complement-inhibiting properties in whole animals. Even after undergoing a single session of dialysis using a pediatric hemodialysis filter with high biocompatibility, healthy animals showed strong complement activation with 5 percent of their C3 being converted to a form that can trigger inflammation and stimulate the immune system.

"This is a huge amount of activation because hemodialysis patients go every two or three days, three times a week, for treatment," says Lambris. Such repetitive complement activation may create a cytokine boost in humans that could fuel the chronic inflammatory response in renal disease patients. When a single dose of the Cp40 compound was administered, the animals displayed a complete suppression of complement, as indicated by C3 activation levels.

A major advantage of this new approach is that it's short-term: "The treatment is only for the time of hemodialysis," Lambris explains. "It's not a lasting inhibition. You start hemodialysis, you give the compound, and you inhibit during hemodialysis. After the procedure, the complement system quickly regains its full activity." This avoids potential concerns about adverse effects caused by long-term complement suppression. Cp40 can also be manufactured at relatively low cost, easing the already-high financial burden of maintenance dialysis for ESRD patients.

Study co-author Daniel Ricklin, PhD, research assistant professor of Pathology and Laboratory Medicine, adds, "Technical challenges make it almost impossible to perform these studies in mice or other small animals in a clinically relevant context, so you have to go to another animal model. I think this new monkey model that we established is a very important step in evaluating disease mechanisms and novel routes of inhibition for this indication."

The Cp40 treatment can be even more cost-effective because, as Ricklin notes, "You may select patients who would benefit most from the treatment, depending on their underlying condition, or have to use filters with lower biocompatibility. Physicians would then have the option of a selective add-on treatment, therefore controlling the treatment cost overall."

Says Lambris, "We're very excited about this, because we feel it's the first time we have an opportunity to try a complement inhibitor in hemodialysis, and it can be something good for so many hemodialysis patients. I feel they're a neglected group of people."

The chances for clinical translation of this novel therapeutic approach are promising since AMY-101, a drug that is based on Cp40, is currently under clinical development, notes Lambris.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sedentary Behavior Precipitates Night-Time Hot Flashes
Gonorrhea
World Alzheimer's Day 2021 - 'Know Dementia, Know Alzheimer's
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Dialysis Urinary Stones In Children Vesico-Ureteric Reflux Causing UTI in Children Hydronephrosis / Antenatal Counseling Kidney Disease Kidney Kidney Health Stones in Urinary Tract Renal Tubular Acidosis Kidney Failure due to Melamine Toxicity 

Recommended Reading
Diabetic Kidney Disease
Diabetic nephropathy refers to kidney damage due very high levels of blood sugar levels in ......
Diet for Kidney stones
Diet for kidney stone should comprise of calcium-rich foods, increased fluid intake. Other dietary ....
Kidney Failure due to Melamine Toxicity
Adulteration of food with melamine results in the formation of kidney stones and kidney failure, ......
Kidney Stone Prevention
Kidney stones are small stones that develop in urine containing increased levels of calcium, uric .....
Dialysis
Dialysis is an artificial process for removing excess water and waste from the blood. Hemodialysis a...
Hydronephrosis / Antenatal Counseling
Currently most pregnant women undergo one or two ultrasound scans during their pregnancy....
Renal Tubular Acidosis
Renal tubular acidosis/RTA results in acid content of the blood being higher than normal and that of...
Stones in Urinary Tract
Ask people who have suffered from urinary stones and they will tell you how excruciating the pain ca...
Urinary Stones In Children
There is a wide misconception that only adults develop stones. On the contrary kidney stones are ver...
Vesico-Ureteric Reflux Causing UTI in Children
Bacterial infection of urinary bladder can cause pain and burning sensation while passing urine. Abn...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use